Kenji Oku

Isehara, 2591193, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 101 publications

When a positive ANA truly matters - evidence from a Danish national cohort.

When a positive ANA truly matters - evidence from a Danish national cohort.

Journal: Rheumatology (Oxford, England)

Published: May 14, 2026

Expression of MS4A4A on synovial infiltrating macrophages is a hallmark of rheumatoid arthritis and reflects disease severity.

Expression of MS4A4A on synovial infiltrating macrophages is a hallmark of rheumatoid arthritis and reflects disease severity.

Journal: Immunological medicine

Published: April 09, 2026

The Impact of Exercise Tolerance Assessed by 6-Min Walking Distance on Clinical Outcomes in Patients With Interstitial Lung Disease Associated With Connective Tissue Diseases.

The Impact of Exercise Tolerance Assessed by 6-Min Walking Distance on Clinical Outcomes in Patients With Interstitial Lung Disease Associated With Connective Tissue Diseases.

Journal: International journal of rheumatic diseases

Published: August 26, 2025

Alternation of anti-NMDA receptor subunit GluN2 antibody in a patient with SLE who promptly developed anxiety after belimumab.

Alternation of anti-NMDA receptor subunit GluN2 antibody in a patient with SLE who promptly developed anxiety after belimumab.

Journal: Immunological medicine

Published: June 02, 2025

A preliminary report on the feasibility of regression-based alignment of diagnostic thresholds for harmonized use of international classification criteria for antiphospholipid syndrome.

A preliminary report on the feasibility of regression-based alignment of diagnostic thresholds for harmonized use of international classification criteria for antiphospholipid syndrome.

Journal: PloS one

Published: April 17, 2025

A retrospective chart review to explore the efficacy and safety of switching to peficitinib in Japanese patients with rheumatoid arthritis and inadequate response to biologic disease-modifying antirheumatic drugs.

A retrospective chart review to explore the efficacy and safety of switching to peficitinib in Japanese patients with rheumatoid arthritis and inadequate response to biologic disease-modifying antirheumatic drugs.

Journal: Modern rheumatology

Published: January 15, 2025

Vaccine-related environments and patient preferences in Japanese patients with autoimmune rheumatic diseases.

Vaccine-related environments and patient preferences in Japanese patients with autoimmune rheumatic diseases.

Journal: Modern rheumatology

Published: December 20, 2024

Effects of cyclophosphamide administration on ovarian dysfunction in pediatric patients with connective tissue diseases: A systematic scoping review.

Effects of cyclophosphamide administration on ovarian dysfunction in pediatric patients with connective tissue diseases: A systematic scoping review.

Journal: Modern rheumatology

Published: February 29, 2024

IgG4-related disease complicated with diffuse and chronic gastrointestinal inflammation leading to small intestinal perforation.

IgG4-related disease complicated with diffuse and chronic gastrointestinal inflammation leading to small intestinal perforation.

Journal: Modern rheumatology case reports

Published: November 21, 2023

A case of dupilumab combination therapy for exacerbation of atopic dermatitis in a patient with eosinophilic granulomatosis with polyangiitis treated with mepolizumab.

A case of dupilumab combination therapy for exacerbation of atopic dermatitis in a patient with eosinophilic granulomatosis with polyangiitis treated with mepolizumab.

Journal: Modern rheumatology case reports

Published: September 06, 2023

Involvement of the complement system in immune thrombocytopenia: review of the literature.

Involvement of the complement system in immune thrombocytopenia: review of the literature.

Journal: Immunological medicine

Published: May 27, 2023

Real-world efficacy of belimumab in achieving remission or low-disease activity in systemic lupus erythematosus: A retrospective study.

Real-world efficacy of belimumab in achieving remission or low-disease activity in systemic lupus erythematosus: A retrospective study.

Journal: Modern rheumatology

Published: May 25, 2023

Showing 1-12 of 101

Last Updated: 09/26/2026